Estados Unidos · Bolsa y Finanzas · Investor's Business Daily

Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval

Publicado por Investor's Business Daily · Estados Unidos hace 1 d

Teva stock surged Friday after the FDA approved its schizophrenia drug, a once-monthly injectable treatment for the disease.

Leer el artículo completo en Investor's Business Daily Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.investors.com)

También te puede interesar

Business Insider

I moved my family from Australia to New York City 12 years ago. It's led to some very expensive regrets.

China passenger vehicle retail market slumps 24% in September

CFTC Draws the Line Between Prediction Markets and Gambling in New Rules

Petra Power looks to modernize energy for data centers and defense vehicles

Kasai, Klarity and 8 other baby names surging in America

JPMorgan makes bullish call in fixed income space, suggests it's a once in a generation opportunity